๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Immunogenicity of a recombinant hepatitis B vaccine (Euvax-B) in haemodialysis patients and staff

โœ Scribed by S.A. Teles; R.M.B. Martins; C.L.R. Lopes; M.A. dos Santos Carneiro; K.P. Souza; C.F.T. Yoshida

Book ID
110366988
Publisher
Springer
Year
2001
Tongue
English
Weight
360 KB
Volume
17
Category
Article
ISSN
0393-2990

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Safety and immunogenicity of a recombina
Safety and immunogenicity of a recombinant hepatitis B vaccine
โœ E. Dandolos; A. Roumeliotou-Karayannis; S. C. Richardson; Prof. G. Papaevangelou ๐Ÿ“‚ Article ๐Ÿ“… 1985 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 340 KB

A hepatitis B vaccine produced in yeast by recombinant DNA technology was evaluated using 5-micrograms and 10-micrograms doses in a randomized trial lasting 7 months in 110 male armed forces recruits aged 17-19 years. Results were compared to those of an identical trial of a plasma-derived vaccine.

Immunogenicity of a yeast-recombinant he
Immunogenicity of a yeast-recombinant hepatitis B vaccine in high-risk children
โœ M. G. Rumi; R. Romeo; M. Bortolini; A. Gringeri; A. R. Zanett; P. M. Mannucci; M ๐Ÿ“‚ Article ๐Ÿ“… 1989 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 391 KB

Horizontal transmission of hepatitis B virus (HBV) from illicit drug users to their contacts, including young children, can be prevented by active immunization against HBV. Yeast-recombinant hepatitis B vaccines are now available for this purpose, but their potential efficacy in such high-risk conta